Implementation of Medication Event Reminder Monitors among patients diagnosed with drug susceptible tuberculosis in rural Viet Nam: A qualitative study. by Drabarek, Dorothy et al.
LSHTM Research Online
Drabarek, Dorothy; Anh, Nguyen T; Nhung, Nguyen V; Hoa, Nguyen B; Fox, Greg J; Bernays, Sarah;
(2019) Implementation of Medication Event Reminder Monitors among patients diagnosed with drug
susceptible tuberculosis in rural Viet Nam: A qualitative study. PLOS ONE, 14 (7). e0219891-
e0219891. DOI: https://doi.org/10.1371/journal.pone.0219891
Downloaded from: http://researchonline.lshtm.ac.uk/4653977/
DOI: https://doi.org/10.1371/journal.pone.0219891
Usage Guidelines:
Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
https://researchonline.lshtm.ac.uk
RESEARCH ARTICLE
Implementation of Medication Event
Reminder Monitors among patients
diagnosed with drug susceptible tuberculosis
in rural Viet Nam: A qualitative study
Dorothy DrabarekID1☯*, Nguyen T. Anh2‡, Nguyen V. Nhung3, Nguyen B. HoaID3, Greg
J. Fox1,2‡, Sarah BernaysID1,4☯
1 Faculty of Medicine and Health, University of Sydney, Sydney, Australia, 2 Woolcock Institute of Medical
Research, University of Sydney, Sydney, Australia, 3 National Lung Hospital, Hanoi, Viet Nam, 4 Faculty of
Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom
☯ These authors contributed equally to this work.
‡ These authors also contributed equally to this work.
* dorothy.drabarek@sydney.edu.au
Abstract
Background
Despite the criticality of adherence to tuberculosis treatment, there is paucity of rigorous
experimental research exploring the efficacy of interventions to promote adherence and a
greater lack of inquiry addressing the integral role of adherence behaviour. The aim of this
formative study was to examine the way in which the Wisepill evriMED Medication Event
Reminder Monitor (MERM) was used among outpatients with drug susceptible pulmonary
tuberculosis.
Methods
In depth interviews were conducted with 20 outpatients receiving treatment from two public
healthcare facilities in Thanh Hoa, a rural province in northern Viet Nam. Patients had been
enrolled in a randomized controlled trial evaluating the effect of using the MERM device
upon adherence for between 1–3 months. The control group used the device without an
alert, while the intervention group used the device with a daily alert and scheduled dosing
history review.
Findings
All 20 patients interviewed were supportive of using the MERM device. Those able to be at
home at the time that their treatment was due (50%) used the device as intended. Patients
who worked all reported separating the time when the box was opened from the time at
which they ingested their medication. Patients expressed fidelity to the prescribed medica-
tion taking time and concerns regarding the portability of the device. Limitations of the study
surround the inclusion of a small sample population that did not experience factors that fur-
ther compromise adherence.
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Conclusions
Data recorded by the box did not always accurately reflect usage patterns. The alert in the
intervention arm was able to support adherence only in patients who did not work while com-
pleting their treatment. MERM implementation can be improved by better aligning prescriber
instructions with patients’ daily routines, and increasing the use of adherence data to guide
adherence support practices. Healthcare staff need to be aware of potential barriers to opti-
mal use of MERM devices. A rigorous qualitative approach to formative assessment is
essential to inform the scale up of new digital technologies.
Introduction
Viet Nam ranks fourteenth among 20 highest tuberculosis (TB) burden countries, with an esti-
mated TB incidence of 133 per 100 000 population [1, 2]. The infection remains a significant
health concern due to both inadequate case-finding [3] and lack of effective strategies with
which to increase rates of patient adherence to curative treatment [4]. Incomplete adherence
reduces efficacy of treatment, contributes to the development of drug resistant strains of Myco-
bacterium tuberculosis, and is an important factor underlying relapse [5, 6]. Additionally,
adherence itself is a complex structural and behavioural issue [4, 7, 8].
Political commitment in Viet Nam has ensured that the National Tuberculosis Program is
able to provide TB screening and treatment according to international recommendations.
However, limited human resources available at public TB clinics precludes direct daily supervi-
sion of treatment by healthcare workers. As in many other high-prevalence settings, TB treat-
ment in Viet Nam is self-administered at home for the vast majority of patients during the
maintenance phase of treatment. New affordable technologies promise to enhance patient care
through remote adherence support and monitoring. A sustained investigative focus on the use
of electronic adherence devices among HIV patients has led to advancements in treatment
approaches for antiretroviral therapy [9, 10], however evidence to support the efficacy of such
devices among TB patients is limited [11–13].
The WHO Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care
(2017 update) recommends the use of digital health interventions as a part of integrated
patient care. Medication Event Reminder Monitor (MERM) devices are a new digital technol-
ogy that records treatment adherence, stores medication and provides alerts at the time treat-
ment is due. These devices aim to enable health facilities to deliver treatment for TB in the
community, while closely monitoring adherence [9, 14, 15]. Electronic treatment monitors
such as the MERM device offer an indirect method of measurement of adherence to treatment.
While having contributed significantly to knowledge of medication taking behavior in various
clinical settings, electronic treatment monitor technologies are not able to record whether the
patient ingested the medication or what dosage was taken [7, 16]. The claim that the MERM
device is accurate in measuring adherence needs to be examined.
A large cluster-randomised trial in China showed that a digital medication monitor
box with dosing reminder alert improved adherence to TB treatment [17]. Other studies have
shown that patients and healthcare staff find MERM devices acceptable and easy to use [11, 15,
18]. However, behavioural enquiry into how participants use the MERM device is lacking.
Such evaluation is a crucial formative step in ensuring optimal use of MERM devices and veri-
fying their accuracy in monitoring adherence to treatment. We conducted a qualitative study
as part of a pilot randomised controlled trial (VAS, trial number ACTRN12618000956202)
that evaluated the efficacy of the device in improving adherence. Our study aimed to explore
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patients’ experiences of integrating device use into daily life, in order to better understand the
technology and contextual factors which may prevent the MERM system from acting effec-
tively as a support and monitor of adherence.
Methods
Study setting
This qualitative study was conducted as a part of the pilot Vietnam Adherence Support (VAS)
Trial. The VAS study was a parallel arm randomised controlled trial (RCT) being conducted in
Thanh Hoa province in northern Viet Nam. Participants in the main study who were allocated
to the intervention group, received a MERM (Wisepill evriMED 1000, Wisepill Technologies,
South Africa) that was equipped with a daily medication reminder alert and digital monitor
that recorded when the box was opened as a proxy measure for ingestion of medication.
Health workers were instructed to use adherence data from individual patients in the interven-
tion group to promote a discussion addressing adherence during the patients’ scheduled
monthly clinic visits. Health workers were trained to explore in their monthly discussions with
intervention participants, factors contributing to suboptimal-adherence, solutions to improve
adherence and adverse event management, if required. If poor use of the MERM device was
detected (the MERM was not opened for 20% of days or more in the previous month) then
patients were to receive a weekly phone call from VAS study staff and additional support
counseling by a health worker. Health workers were also trained in using the MERM device, to
check if it was working properly and how to fix it if it was not. Training was provided to health
workers twice; once prior to recruitment into the main study and again after 50 participants
were recruited. In the control group, patients received a MERM which recorded when the
box was opened, but did not alert the patients to the timing of their doses. Health workers
were not provided with data about control patient adherence for this group and although
monthly check ups were scheduled, they did not include discussions based on the digital
adherence report. According to the report, a day without a record of box opening indicates
one missed dosing event [19]. Due to the MERM device’s inability to measure ingestion of
medication, intended use of the device involved opening it at the scheduled medication taking
time and ingesting medication at the same time.
Participant interviews for the qualitative study were conducted either in an unoccupied for-
mal meeting room in a Yen Dinh District TB Clinic, or an unoccupied formal meeting room
at Thanh Hoa Provincial Lung Hospital. Only the interviewers and the translator were present
during interviews which were scheduled to coincide with monthly check-up and medication
replenishment. Participants who requested interviews outside of the health facilities met with
qualitative study staff in other locations in the community.
Study population
During December 2017 and January 2018, VAS study staff invited consecutive patients
enrolled in the RCT to participate in in-depth interviews to evaluate the acceptability and feasi-
bility of the MERM device intervention. Participants were invited during their monthly check
up visit. Eligibility was subject to being 15 years of age or above with newly diagnosed microbi-
ologically confirmed pulmonary tuberculosis, taking only standard oral therapy for tuberculo-
sis as an outpatient, with at least four months of treatment remaining. Exclusion criteria
included subjects diagnosed with multi-drug resistant TB prior to enrolment and those with
severe mental illness. Enrolment into the VAS RCT was voluntary for patients receiving treat-
ment at Thanh Hoa Lung Hospital and Yen Dinh TB Clinic. These eligibility criteria for the
qualitative study were the same as for the VAS RCT.
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Data collection and analysis
Interviewers asked opened questions drawn from a topic guide of key ideas flexible enough to
adapt the form and sequence of enquiry to the experiences of each participant. The interviews
were conducted jointly by two female researchers, one Vietnamese, one Australian (DD), who
were not known to any of the participants prior to the study. The chief investigator provided
training and supervision to the research team throughout. The researchers did not hold any
personal interests that could bias the study results. In line with appropriate ethical consider-
ations, given the sensitivity of reporting non-adherence and to minimise social desirability
bias, an emphasis was placed on the independence of the qualitative study team from clinic
staff and the confidentiality of all interview accounts. Interviews lasted between 45 and 75 min-
utes. The interviews were audio-recorded and conducted in Vietnamese with simultaneous
translation provided to the Australian researcher who posed additional questions as appropri-
ate, with due care being paid not to disrupt the interview dynamic. Field notes were also taken.
Recorded data were transcribed verbatim by an external transcription service. Translation into
English was done by two Vietnamese researchers who checked each other’s translations for
accuracy. Personal identifying details were removed from the data at transcription stage.
A discussion was held immediately after each interview between researchers and translator
to clarify concepts raised. Daily discussions were held during the data collection process
between the interviewers, translator and chief investigator to consider emerging analytical
ideas, opportunities to refine the interview guide and approach, and to identify theoretical sat-
uration. Thereafter, preliminary codes were developed inductively from interview summaries
and agreed upon by the Australian researcher and chief investigator. A coding framework was
developed and applied to the data. Then, through ongoing coding, case comparison, memo
writing and analytical discussions [20] involving all members of the qualitative research team,
key themes and interpretations were identified. Data were managed using Microsoft Excel.
Feedback from the qualitative study was given to VAS study staff who as a result implemented
a more thorough procedure for monitoring monthly adherence discussions. As the RCT was
ongoing, qualitative study participants did not receive feedback on findings.
Ethical issues
Ethical approval (no. 2017/226) for the RCT and qualitative sub-study was granted by the
HREC of the University of Sydney and the National Lung Hospital, Vietnam. Parental or
guardian consent was not sought for one 15 year old participant, this was approved by the
HREC and the National Lung Hospital ethics committee. Consent was discussed with an illit-
erate participant and their marking of the consent form was witnessed by the researchers and
translator. All participants of the qualitative sub-study provided signed informed consent and
received a modest financial reimbursement in line with local research practice.
Results
Of 24 consecutively patients enrolled in the RCT, 20 (83.3%) agreed to take part in the qualita-
tive study. Each participant was interviewed once. Reasons for non-participation included
patients working in a province different from the clinic (travel distance) or being
uncontactable.
We enrolled 17 males and 3 female patients. This distribution reflects both the profile of
participants in the RCT, and the male predominance among patients with TB in Viet Nam
[21]. At the time of interview, participants had been using the MERM device for between five
to twelve weeks. Patients recruited to the study were of different socio-economic backgrounds
and resided in rural and peri-urban areas in Thanh Hoa Province. Some participants
Implementation of MERMs among patients with DS-TB Viet Nam
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experienced risk factors for non-compliance such as illiteracy, poverty and distance to TB clin-
ics [22], factors that the MERM intervention aims to overcome. One elderly lady was illiterate;
no participants described experiencing abject poverty, however there were three participants
who reported experiencing ongoing financial hardship, which affected their capacity to rest, as
they could not afford not to work throughout their treatment, and to eat well. Another partici-
pant reported receiving government health insurance which is received only by the very poor;
three participants had to travel over 20 km to reach the hospital or clinic, with the furthest dis-
tance travelled being 60 km. There were no participants who experienced more than one risk
factor for non-compliance. Prior to commencing treatment within the public tuberculosis
control program, participants had sought care from private and public commune level clinics,
district hospitals and pharmacies and public tertiary hospitals. Table 1 shows the characteris-
tics of study participants, including their occupations.
The MERM device was reliable, in that it did not falter in its ability to send digital signals
over long distances and in only two instances did the audio alert sound at unexpected times.
For one participant in the control group, upon commencing to use the device the alarm erro-
neously sounded at midnight and for one participant in the intervention group the alarm had
been set by study staff one hour earlier than the medicine taking time prescribed by the doctor.
All participants considered the box to be useful, citing various reasons including keeping the
medication dry, safe and neat and acting as a reminder. Among those who said it was useful in
supporting adherence, there was variation in whom they considered it to be useful for: either
for themselves and others or older people only and not themselves. Several participants noted
that the box might be more beneficial as an adherence reminder tool for people of older age.
However, we found that location of work, away from the home or within the home environ-
ment, rather than age, were the main determinants of how the MERM box was used and its
related efficacy. The association between location of work and use of the MERM device
emerged from the data as the strongest thematic pattern in our analysis. Participants who did
not use the box as intended all worked outside of the home on a daily basis, including those
who were poor and needed to work throughout their treatment. Those who could stay home
Table 1. Qualitative sample overview n = 20.
Age
range
No. MERM with
alert (I)
MERM without
alert (C)
Female Male Working away from the home Working within the home or vicinity of the home
or unemployed
15–19 1 1 1 student
25–29 3 3 3 fabric factory supervisor, financial
manager
college graduate
30–34 1 1 1 farmer
35–39 1 1 1 truck driver
40–44 1 1 1 stone mason
45–49 5 4 1 2 3 farmer/builder farmer, fisherman, fish trader, printing factory
worker
50–54 1 1 building site inspector
55–59 4 4 4 builder farmer/builder, farmer, farmer
60–64 2 1 1 2 farmer, commune leader (retired
electrician)
70–74 1 1 1 rice farmer
Total
n (%)
20
(100)
8 (40) 12 (60) 3 (15) 17
(85)
10 (50) 10 (50)
Note: No participants in the 20–24 years and 65–69 years age groups were enrolled.
I, intervention; C, control
https://doi.org/10.1371/journal.pone.0219891.t001
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during their treatment and use the box as intended were those who were self-employed as
farmers working on land adjacent to their homes or those who were unemployed during treat-
ment, the latter included those who no longer worked due to older age. Those who were unem-
ployed during their treatment expressed that the box would not be as useful if they needed to
leave the home for work each day.
Participant use of the MERM device
The in-depth interviews revealed that ways in which participants used the MERMs were
instrumental in shaping the intervention’s efficaciousness as an accurate monitor and support
of adherence. Upon recruitment to the study, all participants received training from VAS
study staff. Participants reported that they had been instructed to open the MERM box and
take their medication at 8, 8.30 or 9am every day. Some participants described an additional
instruction of either 30 minutes before food or one hour after food, this was an instruction
given by treating doctors and not a requirement of the study. For those in the intervention
arm, the alert on the MERM box was set to coincide with the time that the doctor had pre-
scribed for medication taking or, as for two participants, the time at which the patient thought
it would be most convenient to open the box (but not to take medications). These patients cus-
tomised the time at which their alarm sounded by asking VAS study staff to change it. It was
not clear however, if all participants were aware of such a possibility. Opening the MERM
box and ingesting medication at the same time relied on the participant being in the vicinity of
the device at medication taking time. In recounting how, participants used the MERM device,
it became clear that there were two distinct patterns of use.
Those who used the box as it was intended all or most of the time tended to be those who
were able to stay at home for the majority of each day. This was because when it came to the time
to take their treatment they were close to the box, enabling them to open it, extract their pills and
immediately ingest them. The digital recording of the box being opened was therefore an accu-
rate record of treatment consumption and thus adherence. However, among all 10 participants
who needed to leave their house every day for work, the opening of the box did not indicate
immediate consumption of the pills. Instead, participants would open the box early in the day
before leaving home and carry their daily dose in a more transportable and practical way, such as
in their pocket or bag. No participant who left their house daily used the box or took their medi-
cation as the MERM device manufacturers intended. Participants who were away from home for
more than one day would take as many doses out of the box as days they were away.
A: “Everyday, in the morning ‥ around 7 am, I open the box and bring the drug along.
Except some days that I have to go for two days, I cannot open the box on the next day . . .
Q: Yes, so for those two day trips, how do you do with your drug?
A: I leave the box at home, I just take medicine, put it in the nylon bag and bring it along.”
(P06-TH-C- working)
P16-C took his medication to work with him and there he relied on his own entirely sepa-
rate reminder system in the form of a mobile phone alarm. Younger study participants tended
to set their own alerts on personal electronic devices, demonstrating utility of multiple digital
technologies as adherence supports.
A: “. . . I set the [phone] alarm at three different times, 15 minutes before, 5 minutes before
and 5 minutes later. It reminds me continuously to avoid the situation when you’re too
busy.” (P16-TH-C-working)
Implementation of MERMs among patients with DS-TB Viet Nam
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For most participants in the intervention arm, opening the box before leaving for work also
meant opening the box prior to the alert sounding, rendering the MERM’s reminder alert fea-
ture ineffective in supporting adherence. Upon receiving their MERM box, P12-I and P05-I
had their alert set by study staff to sound at 6.30am and 7am respectively, due to work sched-
ules. However, both participants continued to carry the medication to work and ingest at
9.30am and 9am. No subsequent or other adjustments were reported by intervention arm par-
ticipants. Only P02-I mentioned to a healthcare worker that his routine consisted of separating
the time at which he opened the MERM box from when he ingested medication. He reported
that the healthcare worker said this method of using the box was allowed.
Q: “You open the box at 6:30?
A: Yes. At around 6:30 and 6:40 when I leave the house.
Q: So‥ why are you not taking them right in the morning but waiting until. . .
A: Because the doctor said to take them at around 9:00 and 9:30 in this period. . .”
(P12-TH-I-working)
We examined the reasons behind why participants who were away from their home during
the day developed this behavioural pattern of twinned treatment schedules. We found that it
was driven by two key concerns. The first related to the physical attributes of the box: it was
too big and inconspicuous for participants to carry with them.
A: “. . .I opened the box and took medicine (out of the box) in advance. . . I am afraid if I
brought it along. Every time when I go out, I often take this bag and then put it in a travel
bag with a ziplock.” (P03-YD-I-not working)
Nineteen of 20 study participants did not did not take the box out of their home, the excep-
tion being P14-C, albeit describing doing so as inconvenient.
A: “. . . for a young guy, the box is also inconvenient because it is a little big for us to bring it
along when hanging out or travelling . . . it is cumbersome to take along.” (P14-TH-C-
working)
The MERM box’s lack of practical portability is important to note, in particular that its por-
tability is a feature identified by the manufacturer as key to its usefulness [23]. It is also perti-
nent that some patients described the box as not big enough, in that it did not fit both their TB
medications and the prescribed supplements and vitamins they took daily to counter the
potential toxicities of the medication.
The second driver of how the box was used among study participants who worked, reflects
a nexus of values which shaped the way that participants perceived and interacted with their
prescribing clinicians. Participants described having an unquestioning trust in their doctor
and in the treatment’s ability to cure them of their illness.
A: “In my opinion. . . if you have an illness and you don’t follow the treatment plan of doc-
tors then you shouldn’t go to the hospital at all. . . Now you’re a doctor. You tell me to take
this, take that, I trust you and if then I don’t do things like you said. . . it will become useless,
then what’s the point of going. . . we should obey.” (P05-TH-I-working)
Implementation of MERMs among patients with DS-TB Viet Nam
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A: “Yes, generally if I follow the treatment plan strictly, there wouldn’t be any problems. . .
Lung TB can totally be cured.” (P16-TH-C-working)
We found that congruent with participants’ unquestioning trust in their doctor, they
adhered precisely to the doctors’ instructions for when medication should be taken. These
instructions had not been tailored to fit within the individual’s existing routine. However, par-
ticipants went to considerable efforts to comply with the recommended time for taking medi-
cations. As a result, the act of ingesting the pills became independent of the MERM box in
both time and location. In some cases, participants had inadvertently and unnecessarily com-
plicated their treatment routines by attempting to accommodate both their doctor’s instruc-
tions and their existing habits and routines.
Impact of patterns of use on efficacy
P16-C is an illustrative case which highlights the limitations in the way that the MERM
box was used and the related challenges this poses for how to interpret the digital monitoring
data. This 29 year old man’s digital adherence report, spanning three months, showed that the
box was opened only five or seven times per month. In his interview however, he explained his
meticulous daily routine to ensure that he did not forget any doses (as quoted above).
A: “. . .I was using the box normally but only during the time of my treatment at home.
Since I started going to work, I haven’t been using it that much because I cannot bring it
along. It’s very cumbersome.
Q:‥ so do you take medications out for one day only or for few days?
A: Around three or four days. . . I put them in my backpack just in case I forget so I just put
them in there.” (P16-TH-C-working)
For P16-C, the intervention became ineffective as both a support for adherence and adher-
ence monitor. Without additional corroboration the resulting digital record erroneously indi-
cated that he was a poor adherer.
Discussion
This qualitative study documents use of the MERM device as being viewed positively by outpa-
tients receiving treatment for drug susceptible tuberculosis, and for those able to stay at home
during treatment, the device appears from our analysis to be working as intended. However,
due to how the MERM device came to be used among study participants in both study arms
whose daily routines did not support its proposed pattern of use, the MERM device did not
always fulfil its intended role as a support for adherence. Nor did the intervention provide an
accurate record of adherence for these participants. Digital data reports frequently underesti-
mated adherence and masked the complications of separating the times at which the box was
opened, and medication was taken. Additionally, despite research staff receiving adherence
data from the devices, patients in the intervention group did not report that this information
had been raised in their discussions with a health worker. This represented a missed opportu-
nity to use data provided by the MERM system, which is designed to deliver information to
health practitioners and guide their adherence support. It is possible that health workers were
not appropriately aware of the value of the generated adherence report as a tool with which to
guide counselling, or that the report would not always accurately reflect patterns of use due to
its nature as an indirect measure. Future studies should include interviews with health staff to
Implementation of MERMs among patients with DS-TB Viet Nam
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better understand the interactions between health providers’ understanding of a technology
used to support adherence to treatment and their patients’ uses of it.
The MERM intervention provides the greatest benefit if patients are able to ingest medica-
tions at home when the adherence alert sounds. This can be achieved by customising alerts to
sound at times at which patients wake, sleep or eat. Such an approach would overcome the
identified limitations of the device, and would preclude the need for alternative portable meth-
ods of storage for patients who leave home early. An alternative strategy for patients unable to
consume their medications at home would be the use of smaller, portable, devices. However,
their capacity is not sufficient to store the large volume of medications required for a month of
treatment. Our study suggests that the benefit of using data from MERM devices will be great-
est when doctors explicitly discuss with patients how use of the device can best fit into their
daily routines, and incorporate data from the devices into patients’ monthly clinic reviews.
Such interaction by health staff could also result in improved adherence through a ‘Haw-
thorne’-like effect, and engender a greater sense of support [9, 10].
The limitations of this study should be noted. Study subjects were not representative of all
patients taking treatment for TB in Viet Nam. We did not identify patients experiencing factors
known to substantially increase risk of non-adherence such as substance abuse, mental illness,
HIV co-infection or MDR-TB [24, 25]. As such our conclusions have limited generalisability.
Information regarding substance abuse was collected in a baseline questionnaire carried out by
study staff and completed by all study participants and HIV co-infection status was determined
from participant hospital or clinic medical records. Further enquiry of the kind we have carried
out is necessary among groups of patients whose circumstances further compromise opportuni-
ties for adherence [26]. In addition, given the relatively small sample size, the findings may not
be representative of how all drug-susceptible pulmonary TB patients use the MERM device, nor
is the inconsistent predictive validity of digital dosing histories an original finding [7, 9, 27].
Similarly, a small sample size that included a small proportion of women limited the ability of
our analysis to detect gendered patterns of use. However, the sample elucidated several impor-
tant drivers of ineffectual use of the MERM device in a consecutively recruited study popula-
tion, which to our knowledge have not been reported previously.
This study has several important public health implications for the use of a MERM system
in resource-limited settings. We have shown that implementation may differ substantially
from the recommended approach. Early evaluation of patient and health worker behaviours
and beliefs following implementation of this technology in a new setting will be essential in
optimising its acceptability and clinical impact. Secondly, we have identified substantial inter-
patient variation in the way in which these devices are used. Clinicians ulitising MERM devices
will need to be aware of potential barriers to their optimal use and orient their approach
towards a patient-centred model of care. This will require training staff to be able to detect
ineffectual device use and health worker practices, and to understand the nuances of how digi-
tal technologies operate and affect patient behaviours (and vice versa). Clinicians need to initi-
ate proactive discussions with patients to elicit patterns of and approaches to use not
detectable by the indirect measure that MERM device provides. Additionally, it is important to
demonstrate to clinicians the potential of a technology such as the MERM to assist in targeting
support and limited resources when the device is not being used as intended. Finally, the intro-
duction of new technologies alone is just one part of a broader approach to adherence support.
Technological innovations must be accompanied by sustainable health system strategies to
address and overcome diverse barriers to treatment completion. Conceiving of these devices
purely as ‘monitors’ of patient behaviour fails to recognise the important collaborative nature
of adherence support, as reflected in recently revised WHO treatment guidelines [12].
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Insights gained from our study provide important guidance for the scale-up and integration
of MERM devices into care in resource-limited settings such as Viet Nam. Lessons learned
from this study may also be applicable to patients taking and health staff administering other
long term treatment regimens such as antiretroviral therapy [13] in similar settings. Lastly, our
behavioural investigation directs new angles of enquiry into how the MERM device and system
can positively influence adherence behavior and further inform the development of patient-
centred strategies utilising digital technologies.
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